Pharma Products Liability / Mass Tort

Today’s product liability cases reach far beyond one courtroom, requiring more than a case-by-case approach. King & Spalding’s product liability practice takes a strategic approach to litigation. Recognizing that clients need to protect their businesses, including the continued viability of their products in the marketplace, our lawyers work with our FDA & life sciences practice group and our government investigations team to provide a comprehensive 360° defense.

We add to this strategic approach a range of trial experience that is increasingly unusual in large firms. We try cases every year throughout the nation. With three fellows in the American College of Trial Lawyers, an organization whose members are elected based on actual courtroom experience, we serve notice to opposing counsel that they should not count their cases as settled.

Our trial experience provides many benefits:

• A long track record of defending class actions, having served as lead counsel in hundreds of class actions filed in more than 40 states and having tried class actions to verdict.
  
  
• A team devoted specifically to identifying and preparing medical and scientific expert witnesses and strategically attacking plaintiffs’ experts, resulting in their exclusion on Daubert grounds.
  
  
• A record of successfully representing clients in all of the U.S. Circuit Courts, the U.S. Supreme Court, and in most of the state appellate courts across the country, including plaintiff-friendly jurisdictions when the trial result is virtually pre-ordained.
  
  
• State-of-the-art litigation support capabilities, where we lead the way in developing efficient computer-based litigation support systems to alleviate the burden of discovery while meeting the increasing demands of e-discovery.

Recognitions

• Ranked by The American Lawyer as one of the top three product liability practices in the United States.
  
  
• A nationally recognized product liability practice by Chambers USA, which cited achievements on behalf of clients in the pharmaceutical industry.
  
  
• Named by the National Law Journal to its “Defense Hot List” for two consecutive years.”